KR100893779B1 - The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical - Google Patents

The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical Download PDF

Info

Publication number
KR100893779B1
KR100893779B1 KR1020070045441A KR20070045441A KR100893779B1 KR 100893779 B1 KR100893779 B1 KR 100893779B1 KR 1020070045441 A KR1020070045441 A KR 1020070045441A KR 20070045441 A KR20070045441 A KR 20070045441A KR 100893779 B1 KR100893779 B1 KR 100893779B1
Authority
KR
South Korea
Prior art keywords
angelica
extract
ethanol
free radical
concentrate
Prior art date
Application number
KR1020070045441A
Other languages
Korean (ko)
Other versions
KR20080099636A (en
Inventor
강재선
김천규
백재영
김동희
김강민
홍용근
황성우
구봉주
이진영
정우식
이상길
Original Assignee
인제대학교 산학협력단
강재선
한국생명건강 (주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인제대학교 산학협력단, 강재선, 한국생명건강 (주) filed Critical 인제대학교 산학협력단
Priority to KR1020070045441A priority Critical patent/KR100893779B1/en
Publication of KR20080099636A publication Critical patent/KR20080099636A/en
Application granted granted Critical
Publication of KR100893779B1 publication Critical patent/KR100893779B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 유해 활성산소(free radical) 소거 효과가 있는 참당귀 추출물의 추출방법에 관한 것이다. The present invention relates to a method for extracting the Angelica gigas extract having a free radical scavenging effect.

유해 활성산소(free radical) 소거효과가 있는 참당귀 추출물은 그 주성분이 데커신과 데커시놀 안젤레이트가 90% 이상으로 구성된 액체 농축물이며, 본 발명은 참당귀 추출물은 인체에 투여 가능한 형태로 물과 에탄올로만 추출하였고, 또한 고 순도를 위하여 온도와 용해도 차이를 이용한 정제방법을 이용한 것이다. Charcoal Angelica extract with toxic free radical scavenging effect is a liquid concentrate composed of more than 90% of the major components of the decancin and decosinol angelate, the present invention is that the Angelica Angelica extract is in the form of water that can be administered to the human body Extracted only with and ethanol, and also using a purification method using the difference in temperature and solubility for high purity.

Angelica gigas Nakai, Decursin, Decursinol angelate, antioxidant, free radical  Angelica gigas Nakai, Decursin, Decursinol angelate, antioxidant, free radical

Description

유해 활성산소 소거효과가 있는 참당귀 추출물의 추출방법{The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical} The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical}

도1는 추출 정제된 96% 순도의 참당귀 추출 농축 정제물1 is an extract-purified concentrated purified Angelica gigas of 96% purity

도2은 참당귀(Angelica gigas Nakai)에서 추출 분리 정제한 데커시놀, 데커신 및 데커시놀 안젤레이트의 HPLC분석자료 및 구조 Figure 2 Angelica Angelica HPLC Analysis and Structure of Decosinol, Decosin and Decosinol Angelate Extracted and Purified from gigas Nakai)

참당귀는 한국이 원산지로서 그 사용 범위가 보혈제로서 한방약제로 이용되어져 왔으며 최근에는 한국산 지표물질인 데커신과 주요 성분인 데커시놀이 혈류개선 작용과 항 헬리코박터 작용이 있다고 보고되어 있으며 본 발명자 등이 밝힌 순수 정제된 데커신이 신장독성 억제와 당뇨합병증에 의한 신부전증의 예방 효과 및 당뇨성 고혈압에 효과가 있음을 동물실험을 통하여 밝힌 바 있다.Champagne Angelica has been used as a Korean medicine as a blood donor as a country of origin, and recently, it has been reported that Decacin, a Korean indicator, and Decacinol, a major ingredient, have blood flow improvement and anti-Helicobacter action, and the inventors have revealed pure water. It has been shown in animal experiments that purified decosin is effective in inhibiting kidney toxicity, preventing renal failure due to diabetic complications, and diabetic hypertension.

(PCT/ KR99 /00632). ( PCT / KR99 / 00632 ).

"강" 등이 밝힌 참당귀 추출물의 항산화 효과에 대한 연구결과가 발표되었는데 이 경우에는 열수 추출물을 사용한 추출물의 항산화 효과와 70%메탄올을 사용하여 3회추출하여 단순 농축하여 사용한 사례가 발표되어 있다. ( 한국식품영양과학회지, Vol.33, No.7, page 1112~1118, 2004년, 2004년 대한지역사회영양학회 춘계학술대회 poster 발표 )      A study on the antioxidant effect of Angelica gigas extract disclosed by "Kang" was published. In this case, the antioxidant effect of the extract using hot water extract and three times using 70% methanol were extracted and then concentrated. . (Korean Journal of Food and Nutrition Science, Vol. 33, No.7, page 1112 ~ 1118, 2004, 2004 Poster presented at the Korean Society of Community Nutrition Conference Spring Conference)

“강 ” 등의 연구결과는 열수 추출물 또는 70% 메탄올 추출물을 단순 농축하여 항산화 효과를 실험한 것으로 그 결과는 참당귀 열수 추출물 1mg/ml의 free radical 소거효과는 66.3%이며 , 70%메탄올 추출물 1mg/㎖의 소거효과는 81.5%로 보고되어 있으나 약효성분에 대한 분석결과는 표시되지 않았다. 즉 Decursin과 Decursinol angelate를 고 정제하여 실험한 것은 아니다.      The research results of “Kang” and others were tested for the antioxidant effect by simply concentrating hot water extract or 70% methanol extract. The results showed that 1mg / ml of Cangdong Angelica hot water extract had a free radical scavenging effect of 66.3%, and 70% methanol extract 1mg. / Ml scavenging effect was reported as 81.5%, but the analysis results for the active ingredient was not shown. In other words, decursin and decursinol angelate were not highly purified and tested.

그리고 본 발명자는 기존의 방법보다 간편하고 추출량을 다량 확보할 수 있는 농축 방법을 확보하여 제조하였고 이것을 액제로 제조하여 실험동물에 경구적으로 투여 할 때 장관에서 용이하게 흡수되는 것을 확인 할 수 있었다.      In addition, the inventors of the present invention prepared and secured a concentration method that is simpler than the existing method and secured a large amount of extraction, and it was confirmed that the solution was easily absorbed in the intestine when administered orally to the experimental animals.

데커신과 데커시놀 안젤레이트는 구조 이성질체로서 현재까지 잘 알려져 있지 않았으나 본 발명자 등이 그 작용을 연구하여 왔으며 그 분석법에 관한 것도 확립하여 밝힌바 있다.(한국특허 등록번호:0509843)      Decusin and decosinol angelate have not been well known as structural isomers until now, but the present inventors have studied the action and have also established and analyzed the analysis method (Korean Patent Registration No .: 0509843).

데커신은 실온에서 고체로 존재할 수 있으나 데커시놀 안젤레이트는 영하 70도에서도 액체로 존재하며 참당귀에서는 데커신과 데커신놀 안젤레이트의 비율이 약 3 : 2정도 인 것으로 본 발명자 등이 이미 밝혔으며, 본 연구를 통하여 정제 후 Mass분석을 통한 정확한 함량 및 비율을 살펴본 결과 추출물(100%) 중 Decursin 50~54.5%, Decursinol angelate 40~42%, Decursinol 0.1~0.3%, 데커시놀 유도체 약 2~3%, 기타 1~2%로 구성된 정제물질을 확보하였다.       Decasin may be present as a solid at room temperature, but decosinol angelate is present as a liquid even at minus 70 degrees, and in the Angelica gigas, the ratio of decosinol to decansinol angelate is about 3: 2. After purifying through this study, the exact content and ratio through mass analysis showed that Decursin 50 ~ 54.5%, Decursinol angelate 40 ~ 42%, Decursinol 0.1 ~ 0.3%, Decosinol derivatives about 2-3 Purified material consisting of% and other 1-2% was secured.

이런 결과는 기존의 데커신과 데커시놀 안젤레이트의 비율이 60대 40 즉 3 : 2의 비율과 약간의 차이를 보이는 평균 57 : 43 비율을 나타내었다. 또한 데커신류의 함량은 90%이상으로 기대이상의 결과를 도출하였다. 기존의 알콜 추출방법이나 70%알콜 추출방법으로는 참당귀에 존재하는 데커신의 함량이 추출 농축액의 35%내외인 것으로 알려져 왔고 그 양이 50%를 넘지 않았지만 본 연구자의 결과로서 99%이상의 주정 알콜 및 약전 에탄올을 사용하였을 때 그 농축된 함유량이 높게 나와 최대 75% 이상 88%까지 함유하는 결과를 도출한 바 있다. (한국특허 등록번호:0509843)       These results indicated that the ratio of Deckersin and Dekersinol Angelate was 57:43, which was slightly different from that of 60 to 40, that is, 3: 2. In addition, the content of deckerin was above 90%, which resulted in more than expected results. The existing alcohol extraction method or 70% alcohol extraction method has been known that the content of decusin present in Angelica gigas is about 35% of the extract concentrate and the amount is not more than 50%, but as a result of this study, more than 99% alcohol alcohol And when the pharmacopeia ethanol was used, the concentrated content was high, resulting in containing up to 75% or more and 88%. (Korean patent registration number: 0509843)

본 연구는 기존방법을 개선하여 온도와 용해도 차이를 이용하여 순도를 높이는 방법을 개발하고자 하였다.       This study aims to develop a method to improve the purity by using the difference of temperature and solubility by improving the existing method.

본 발명은 유해 활성산소(free radical) 소거에 탁월한 효과가 있는 데커신 및 데커시놀 안젤레이트를 유효성분으로 하는 참당귀추출물을 의약품이나 식품에 직접 사용할 수 있는 실용성이 있는 에탄올을 이용하여 순도 90%이상의 고 순도물로서 데커신 및 데커시놀 안젤레이트를 함유하는 참당귀 추출농축물을 생산하는 방법을 제공하는 것에 그 목적이 있다. The present invention provides purity 90 using practical ethanol, which can be used directly in medicine or foods, as the active extract of Angelica gigas extract, which is an active ingredient of decusin and decosinol angelate, which has an excellent effect on eliminating harmful free radicals. It is an object of the present invention to provide a method for producing a Angelica gigas extract concentrate containing decansin and decosinol angelate as high purity of more than%.

상기와 같은 목적을 달성하기 위하여 본 발명은 이미 개발된 정제법을 개선하여, 이번에 개발된 정제법은 주성분함량이 90%이상을 가질 수 있도록 에탄올과 물 그리고 온도, 용해도를 이용하여 참당귀 추출농축물을 생산하는 것을 특징으로 하며, 또한 본발명은 이렇게 해서 생산된 참당귀 추출농축물이 유해 활성산소(free radical) 소거에 탁월한 효능을 가지며 안정성면에서 우수한 항산화제(anti oxidant)로서 이용하는 것을 특징으로 한다. In order to achieve the above object, the present invention improves the purification method already developed, and this time the purification method developed by using ethanol and water and temperature, solubility so that the main component content can be more than 90% The present invention is characterized by producing water, and the present invention is characterized in that the extract extracted from Angelica gigas extract has excellent efficacy in eliminating harmful free radicals and is used as an excellent anti oxidant in terms of stability. It is done.

. .

기존의 정제방법으로는 90% 이상의 정제를 위해서는 유기용매 등을 사용해야하는데 유기용매는 잔류성이나 독성 및 역한 냄새가 존재하나 이번에 개발된 방법은 이런 문제를 발생시키지 않는 간단하면서도 경제적인 방법이며 정제 후 식품용이나 의약품용으로 직접 사용가능하다. 참당귀 추출 농축 정제 혼합물인 데커신 및 데커시놀 안젤레이트와의 병용 사용에 의해 효과적으로 유해 활성산소(free radical)을 제거할 수 있을 것으로 판단된다.       Conventional purification methods require the use of organic solvents for the purification of more than 90%. Organic solvents have residual, toxic, and adverse odors, but the developed method is a simple and economical method that does not cause this problem. Can be used directly for medicine or medicine. It is considered that the free radicals can be effectively removed by the combined use of decansin and decosinol angelate, which is a concentrated extract mixture of Angelica gigas.

본 발명에서 주장하는 것은 의약품이나 식품에 직접 사용할 수 있는 실용성이 있는 에탄올을 이용하여 순도 90%이상의 고 순도물로서 데커신 및 데커시놀 안젤레이트를 함유하는 복합물을 제조하여 이용하는 것이다. 또한 데커신 및 데커시놀 안젤레이트를 유효성분으로 하는 참당귀추출물을 이용하여 항산화효과 등이 탁월하고 안전성면에서도 우수하여 항산화제(anti oxidant)로 사용하고자 한다.       It is claimed in the present invention to prepare and use a complex containing deckercin and decosinol angelate as a high purity product having a purity of 90% or more using practical ethanol which can be used directly in medicine or food. In addition, by using the Angelica Angelica extract as the active ingredient of decusin and decosinol angelate, the antioxidant effect is excellent and safety is intended to be used as an antioxidant (anti oxidant).

일반적으로 한국산 참당귀 (Angelica gigas Nakai)의 주요 성분인 데커신 (decursin), 데커시놀 안젤레이트 (decursinol angelate), 데커시놀 (decursinol), 및/ 또는 이들을 2종 이상 포함하는 당귀추출물의 효과에 대하여는 많은 연구가 있어 왔는데, 참당귀 (Angelica gigas Nakai)로부터의 추출물은 전통적으로 빈혈치료, 진정제, 진통제 등으로 사용되어져 왔다.(D.J. Jung, A. Porzel, S. Huneck, Gigasol and other coumarins from Angelica gigas. Phytochemistry, 30, 710-712, 1991) Common Korean Angelica Angelica Much research has been conducted on the effects of decursin, decursinol angelate, decursinol, and / or two or more of the main components of gigas Nakai. , Angelica ( Angelica Extracts from gigas Nakai have traditionally been used to treat anemia, sedatives, painkillers, etc. (DJ Jung, A. Porzel, S. Huneck, Gigasol and other coumarins from Angelica gigas.Phytochemistry, 30, 710-712, 1991 )

큐마린 유도체인 데커신과 데커시놀 안젤레이트의 다양한 생리활성이 보고되고 있음에도 불구하고 이들의 체내동태에 대한 정보가 부족한 이유는 보다 순수하게 분리 정제하는 기술이 보유되지 않았고, 혈중에서의 정량법의 개발이 어려웠기 때문이라 사료된다. Despite the fact that various biological activities of the decursin and decosinol angelate derivatives have been reported, the lack of information on their physiological dynamics has not been achieved through the technology of purely separating and purifying them. This is because it was difficult.

세포내에서 발생하는 유해 활성산소(free radical)가 지질, 단백질, 핵산 등의 생체 분자들을 변화시켜 노화현상을 초래한다. 이러한 유해 활성산소(free radical)는 정상적인 대사과정에서도 소량 생성되며, 흡연, 세균감염, 공해, 질병상태나 과도한 스트레스, 자외선 노출 시 과잉으로 생성될 수 있다. 이렇게 체내에서 과잉으로 생성된 유해 활성산소(free radical)는 생체의 항산화방어 메카니즘을 깨트려 지질과산화, DNA 변형, 병리 생리학적인 이상상태를 초래한다. 따라서 이러한 항산화 메카니즘을 견고히 하는 것은 결국 건강을 유지하고 노화를 지연시킨다고 볼 수 있다.      Hazardous free radicals generated in cells change the biomolecules such as lipids, proteins, and nucleic acids, leading to aging. These harmful free radicals are produced in small amounts in normal metabolic processes, and can be produced excessively during smoking, bacterial infections, pollution, disease or excessive stress, and UV exposure. The excess free radicals produced in the body break down the antioxidant defense mechanisms of the living body, resulting in lipid peroxidation, DNA modification, and pathological physiological abnormalities. Therefore, solidifying these antioxidant mechanisms can be said to maintain health and delay aging.

본 발명에서 실시한 참당귀 추출농축물의 유해 활성산소(free radical) 소거작용을 조사하였다. 그 결과 참당귀 추출농축물은 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl) 에탄올 농도의 50%를 감소시키는데 필요한 시료농도 (SC50)가 0.047 중량%정도였고 이것은 항산화 효과가 뛰어나다고 알려진 상황버섯 추출물(특허 등록공고 제10-0206538호)의 SC50 값이 0.23 중량%인 것과 chondroitin (Purity 90%) (특허 등록공고 제 10-0365242)의 SC50 값이 0.56 중량%인 것과 약콩 사포닌 (특허 등록공고 제 10-0566857)의 SC50 값이 약 0.34 중량%인 것과 비교해 매우 우수한 것으로 나타났다. 따라서 본 발명의 결과로 참당귀 추출농축물의 항산화 효과는 다른 어떤 물질보다도 우수하였다. The free radical scavenging effect of the extract of Angelica gigas extract was carried out. As a result, the Angelica gigas extract concentrate had a sample concentration (SC 50 ) of 0.047 weight that was required to reduce 50% of the ethanol concentration of 1,1-diphenyl-2-picrylhydrazyl. It was about%, which means that SC 50 value of S. mushroom extract (Patent No. 10-0206538) is known to be excellent in antioxidant effect and 0.23% by weight of SC 50 and SC of chondroitin (Purity 90%) (Patent No. 10-0365242) It was found to be very good compared to the 50 value of 0.56% by weight and the SC 50 value of the soybean saponin (Patent Publication 10-0566857) about 0.34% by weight. Therefore, as a result of the present invention, the antioxidant effect of the extract of Angelica gigas extract was superior to any other substances.

(( 실시예Example ))

이하, 본 발명의 실제 실험 예를 상세히 설명한다.Hereinafter, the actual experimental example of the present invention will be described in detail.

이하의 실험 예에서는 참당귀로부터 주성분 데커신 및 데커시놀 안젤레이트를 90%이상 더욱 바람직하게는 95%이상 함유토록 하는 추출방법에 관한 것과 이 추출물을 이용하여 항산화 활성에 대한 시험결과를 예시한 것이다. The following experimental example relates to an extraction method containing 90% or more, more preferably 95% or more, of the main components of decancin and decosinol angelate from Angelica gigas and illustrates the results of the antioxidant activity using the extract. will be.

[[ 실시예Example 1]  One] 데커신의Decker 용해도 산출 Solubility output

순수하게 합성 정제된 데커신을 이용하여 용해도를 산출하였다. 데커신 100 mg을 60% 에탄올 10㎖에 투입 후 잘 섞어주고 녹지 않은 물질을 10,000 rpm에서 1분간 원심분리하여 침전시키고 상등액을 제거한 후 침전한 물질의 양을 계산하였다. 100 mg에서 침전된 양을 빼주어 계산한 결과로서의 용해도가 6.6 mg/㎖ (60% 에탄올)임을 밝혔다. 또한 같은 방법으로 산출한 100% 에탄올에서의 용해도가 약 4,870 ㎎/㎖ 내외임을 밝혔다. 이 특성을 이용하여 재결정에 사용하여 순도를 높이는데 이용하였다. Solubility was calculated using purely synthetic purified decusin. 100 mg of decusin was added to 10 ml of 60% ethanol, mixed well, and the undissolved material was precipitated by centrifugation at 10,000 rpm for 1 minute, the supernatant was removed, and the amount of precipitated material was calculated. The solubility as a result of subtracting the amount precipitated from 100 mg was found to be 6.6 mg / mL (60% ethanol). In addition, the solubility in 100% ethanol calculated by the same method was about 4,870 mg / ml. It is said to be internal and external. This property was used for recrystallization to increase the purity.

[[ 실시예Example 2] 고 함유  2] high content 농축물Concentrate 제조 방법 Manufacturing method

참당귀로부터 데커신 및 데커시놀 안젤레이트를 분리 농축하는 방법으로서 한국산 및 북한산 당귀인 참당귀를 이용하여 실시하였다. 중국 원산지, 일본 원산지, 베트남 원산지의 경우에는 함량이 적어 경제적으로 가치가 없다.As a method of separating and concentrating Decusin and Decusinol Angelate from Angelica gigas, it was carried out using Korean Angelica gigas, Korean Angelica gigas. Originating in China, originating in Japan, and originating in Vietnam are of low content and are not economically valuable.

식품용 및 의약용으로 사용키 위하여 추출 용매는 약전 에탄올 및 주정 알콜을 사용하였고 물을 사용할 때는 정제수를 사용하였다. 원료인 참당귀를 40메시 (40 mesh)이하로 잘게 분쇄하여 수분함량 5% 이하로 건조하고 약전용 알콜 또는 주정알콜 (이하 ‘에탄올’로 표기)로 분쇄 참당귀의 2배에서 4배를 첨가하여 12시간이상 충분히 추출하였고 이것을 여과하여 정량하였다. 이 경우에는 농축물에 함유된 데커신과 데커시놀 안젤레이트의 함량이 33% 이었다. For the food and medicinal purposes, the extraction solvent was ethanol and alcohol alcohol, and purified water was used when using water. Grind the raw Angelica Angelica to less than 40 mesh (40 mesh), dry it to 5% or less of moisture, and add 2 to 4 times the amount of Angelica Angelica pulverized with medicinal alcohol or alcohol (hereinafter referred to as 'ethanol'). After 12 hours, the extract was sufficiently extracted and filtered. In this case, the content of decusin and decosinol angelate in the concentrate was 33%.

이 농축물을 증발 건고하여 점성이 높은 물질을 얻었다. 이 물질 1 킬로그람당 에탄올 1리터를 넣어 주성분을 녹이고 영하 20도에서 10시간 방치하여 생성된 침전물을 원심분리하여 제거 후 상등액을 얻었다. 상등액을 증발건고하여 농축물을 얻었다.This concentrate was evaporated to dryness to obtain a highly viscous material. 1 liter of ethanol per kilogram of this substance was dissolved to dissolve the main component, and the resulting precipitate was left at 20 ° C for 10 hours to remove the precipitate, which was then centrifuged to obtain a supernatant. The supernatant was evaporated to dryness to give a concentrate.

이 농축물에 60% 에탄올(희석 에탄올) 50 리터을 넣어 용출하였다. 이 경우에 농축물에 함유된 데커신과 데커시놀 안젤레이트는 330그람으로 60% 에탄올 50 리터에 녹을 수 있는 주성분의 량 또한 330 그람인 것을 이용하였다. 50 liters of 60% ethanol (diluted ethanol) was added to this concentrate and eluted. In this case, the concentrations of Decusin and Decusinol Angelate contained in the concentrate were 330 grams and the amount of the main component that could be dissolved in 50 liters of 60% ethanol was also used.

용출 후 원심분리하여 60% 에탄올 층만을 얻었다. 이것을 증발건고하여 농축물을 얻을 수 있었다. 이것을 99% 알코올에 녹여 상등액을 취하여 최종 농축물을 얻었다. (도1참조)After elution, centrifugation gave only a 60% ethanol layer. This was evaporated to dryness to give a concentrate. This was dissolved in 99% alcohol and the supernatant was taken to give the final concentrate. (See Fig. 1)

이것을 액체크로마토그램 (HPLC)으로 분석한 대표적인 결과는 다음과 같으며 함량은 데커신 54.52%, 데커시놀 안젤레이트 41.26%, 데커시놀 0.299%로 총 함량은 96%를 보였고 데커신 유도체가 2.5%를 보였다. 확정시험은 Mass spectrophotometer를 이용하여 분자량으로 하였다. 각각의 분자량은 MW 328.35, MW 328.35, MW 246.25 이었다. (도2 참조) Representative results of the liquid chromatography (HPLC) are as follows, the content of decosin 54.52%, decosinol angelate 41.26%, decosinol 0.299%, the total content was 96% and the decosin derivative 2.5 Showed%. Confirmation test was carried out using a mass spectrophotometer as the molecular weight. Each molecular weight was MW 328.35, MW 328.35, MW 246.25. (See Figure 2)

Figure 112007034717463-pat00001
Figure 112007034717463-pat00001

[실시예 3] 유해 활성산소(free radical) 소거 효과Example 3 Hazardous Free Radical Scavenging Effect

실시예 2에서 추출 정제한 참당귀 추출물을 이용하였다. 즉 96%의 순도를 갖는 데커신, 데커시놀 안젤레이트, 데커시놀을 주성분으로 하는 참당귀 추출물을 이용하였다. 유해 활성산소 소거 작용효과를 관찰한 것이다. The chaff extract extracted from Example 2 was used. In other words, the extract of Angelica gigas was used as a main component of the decansin, decosinol angelate, decosinol having a purity of 96%. Toxic free radical scavenging effect was observed.

0.2 mM 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl) ethanol용액 0.5 ㎖ 에 에탄올을 용매로 하여 조제한 여러 농도의 시료를 1 ㎖ 넣 고 37℃에서 30분간 방치 후 517 nm에서 흡광도를 측정하였다. 그 결과, 유해 활성산소(free radical) 소거능력과 유해 활성산소(free radical)을 50% 감소시키는 농도 (SC50)은 아래식과 같이 구하였다. (시료의 유해 활성산소(free radical) 소거능력은 유해 활성산소 소거활성(scavenging activity, SC50)으로 표시할 수 있으며, 여기서 SC50은 DPPH(1,1-diphenyl-2-picrylhydrazyl)의 농도가 50% 감소하는데 필요한 시료의 농도로 나타난다)To 0.5 ml of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl ethanol solution, 1 ml of various concentrations prepared by using ethanol as a solvent, Absorbance was measured at 517 nm after standing for a minute. As a result, the concentration (SC 50 ) that reduces the harmful free radicals and the free radicals by 50% was calculated as follows. (Free radical scavenging ability of the sample can be expressed as scavenging activity (SC 50 ), where SC 50 is the concentration of DPPH (1,1-diphenyl-2-picrylhydrazyl) Results in a concentration of sample required to decrease by 50%)

본 실시예에서 SC50은 0.047중량% 로 나타났다 (표1). SC50의 수치는 DPPH Inhibition ratio (%) 의 값이 50%를 보이는 지점을 의미한다.In this Example, SC 50 was found to be 0.047 wt% (Table 1) . The value of SC 50 means the point where the value of DPPH Inhibition ratio (%) shows 50%.

이것은 항산화 효과가 뛰어나다고 알려진 상황버섯 추출물(특허 등록공고 제10-0206538호)의 SC50 값이 0.23 중량%인 것과 chondroitin (Purity 90%) (특허 등록공고 제 10-0365242)의 SC50 값이 0.56 중량%인 것과 약콩 사포닌 (특허 등록공고 제 10-0566857)의 SC50 값이 약 0.34 중량%인 것과 비교해 매우 우수한 것으로 나타났다. 따라서 본 발명의 결과로 참당귀 추출농축물의 항산화 효과는 다른 어떤 물질보다도 우수하였다. This is the SC 50 the value of the antioxidant effect is excellent and known linteus extract SC 50 value is 0.23% by weight as chondroitin (Purity 90%) (Patent Registration Publication No. 10-0365242 of the Patent Registration No. 10-0206538 Bulletin) It was found to be very good compared to 0.56% by weight and the SC 50 value of the weak bean saponin (Patent Publication 10-0566857) was about 0.34% by weight. Therefore, as a result of the present invention, the antioxidant effect of the extract of Angelica gigas extract was superior to any other substances.

<표 1>TABLE 1

Figure 112007034717463-pat00002
Figure 112007034717463-pat00002

* DPPH(1,1-diphenyl-2-picrylhydrazyl) Inhibition ratio (%) DPPH (1,1-diphenyl-2-picrylhydrazyl) Inhibition ratio (%)

= [1- (E -B)/ C] x 100           = [1- (E -B) / C] x 100

. B (Blank) - EtOH 0.5 ㎖ + test sample 1 ㎖      . B (Blank)-0.5 ml of EtOH + 1 ml of test sample

. C (Control) - 0.2 mM DPPH 0.5 ㎖ + solvent 1 ㎖       . C (Control)-0.5 ml of 0.2 mM DPPH + 1 ml of solvent

. E( Experimental) - 0.2 mM DPPH 0.5 ㎖ + test sample 1 ㎖       . E (Experimental)-0.5 ml of 0.2 mM DPPH + 1 ml of test sample

이상 상기 실시예를 통하여 명백히 알 수 있는 바와 같이, 본 발명이 제공하는 참당귀(Angelica gigas Nakai)에서 정제된 농축물은 고순도 정제물로서 에탄올과 물만을 사용한 정제법으로 의약품 또는 식품으로 개발할 때 매우 유용한 것이며, 고순도의 데커신과 데커시놀 안젤레이트를 주성분으로 함유토록하기 위하여 온 도에 따른 용해도의 차이 및 에탄올과 물의 혼합비율에 따르는 용해도 차이를 이용하여 고 순도 물질을 얻었다. 참당귀(Angelica gigas Nakai)에서 정제된 농축물( 데커신, 데커시놀 안젤레이트 , 데커시놀 )은 유해 활성산소(free radical) 소거작용을 통한 항산화제(anti oxidant)로서 산업상 이용이 가능한 유용한 발명이 될 것이다. As can be clearly seen through the above embodiment, Angelica Angelica provided by the present invention ( Angelica The concentrate purified from gigas Nakai) is a high-purity refinement using only ethanol and water, which is very useful when developing into pharmaceuticals or foods, and contains high purity decansin and decusinol angelate as main ingredients. High purity material was obtained using the difference in solubility and the difference in solubility according to the mixing ratio of ethanol and water. Angelica Angelica Concentrates purified from gigas Nakai (deckerin, decosinol angelate, decosinol) have become useful inventions that can be used industrially as anti-oxidants through toxic free radical scavenging. will be.

Claims (7)

삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 원료인 참당귀를 40메시(mesh)이하로 잘게 분쇄하여 수분함량 5%이하로 건조하고 분쇄한 참당귀에 분쇄 참당귀의 2배에서 4배의 약전용 알콜 또는 주정 알콜을 첨가하여 진탕하에서 추출하고 농축하여 점성이 높은 물질을 얻는 단계 ; Grind the raw Angelica Angelica to less than 40 mesh and dry it to less than 5% water content, and extract it under shaking by adding 2 to 4 times more medicinal alcohol or alcohol to the ground Angelica Angelica. And concentrating to obtain a highly viscous material; 이 물질 1 킬로그람당 약전용 알콜 또는 주정 알콜 1리터를 넣어 주성분을 녹이고 영하 20도에서 10시간 방치하여 생성된 침전물을 원심분리하여 제거한 후 상등액을 얻고 상등액을 증발건고하여 농축물을 얻는 단계 ;Adding 1 liter of medicinal alcohol or spirit alcohol per kilogram of this substance to dissolve the main ingredient, and leave the precipitate at 10 ° C. for 10 hours to remove the resulting precipitate by centrifugation to obtain a supernatant and to evaporate and dry the supernatant to obtain a concentrate. 이 농축물에 주성분의 용해도를 이용하여 60% 에탄올을 사용하여 가용화 시키는 단계 ;Solubilizing the concentrate with 60% ethanol using the solubility of the main component in the concentrate; 60% 에탄올에 녹지 않는 불순물을 원심분리하여 제거하는 단계 ;Centrifuging and removing impurities insoluble in 60% ethanol; 60% 에탄올층을 취하여 증발 건고하는 단계:Take 60% ethanol layer and evaporate to dryness: 증발건고된 물질을 99% 에탄올에 녹여 상등액을 취하는 단계 :Take the supernatant by dissolving evaporated material in 99% ethanol: 이 상등액을 재 증발건고하여 데커신, 데커시놀, 데커시놀 안젤레이트를 순도 90 중량% 이상 함유하는 것을 특징으로 하는 참당귀 추출농축물의 생산방법.The supernatant is re-evaporated to dryness, and the method of producing a extract of Angelica gigas extract, characterized in that it contains at least 90% by weight of decancin, decansinol, and decansinol angelate.
KR1020070045441A 2007-05-10 2007-05-10 The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical KR100893779B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070045441A KR100893779B1 (en) 2007-05-10 2007-05-10 The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070045441A KR100893779B1 (en) 2007-05-10 2007-05-10 The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical

Publications (2)

Publication Number Publication Date
KR20080099636A KR20080099636A (en) 2008-11-13
KR100893779B1 true KR100893779B1 (en) 2009-04-20

Family

ID=40286577

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070045441A KR100893779B1 (en) 2007-05-10 2007-05-10 The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical

Country Status (1)

Country Link
KR (1) KR100893779B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101233967B1 (en) * 2010-11-26 2013-02-18 경성대학교 산학협력단 Makgealli comprising decursine and/or decursinol angelate and manufacturing method thereof
KR20160096883A (en) 2015-02-06 2016-08-17 경성대학교 산학협력단 Pharmaceutical Composition For Treating Hyperlipidaemia
KR20210150829A (en) 2020-06-04 2021-12-13 경성대학교 산학협력단 Composition for treating of rhinitis comprising Angelica gigas extracts and indirubin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010080265A (en) * 1998-10-22 2001-08-22 정세영 Pharmaceutical composition containing decursin
KR100509843B1 (en) * 2003-03-14 2005-08-24 주식회사 바이넥스 Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai
KR20050089786A (en) * 2005-08-27 2005-09-08 김형환 Blood vessel relaxational agent containing decursin or decursinol angelate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010080265A (en) * 1998-10-22 2001-08-22 정세영 Pharmaceutical composition containing decursin
KR100509843B1 (en) * 2003-03-14 2005-08-24 주식회사 바이넥스 Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai
KR20050089786A (en) * 2005-08-27 2005-09-08 김형환 Blood vessel relaxational agent containing decursin or decursinol angelate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101233967B1 (en) * 2010-11-26 2013-02-18 경성대학교 산학협력단 Makgealli comprising decursine and/or decursinol angelate and manufacturing method thereof
KR20160096883A (en) 2015-02-06 2016-08-17 경성대학교 산학협력단 Pharmaceutical Composition For Treating Hyperlipidaemia
KR20210150829A (en) 2020-06-04 2021-12-13 경성대학교 산학협력단 Composition for treating of rhinitis comprising Angelica gigas extracts and indirubin

Also Published As

Publication number Publication date
KR20080099636A (en) 2008-11-13

Similar Documents

Publication Publication Date Title
US20160151440A1 (en) A Novel Composition of Curcumin with Enhanced Bioavailability
AU2012338742B2 (en) Composition comprising chicory extract
RU2426552C2 (en) Extracts of phaseolus vulgaris, their application and compositions containing them
CN111249338A (en) Cistanche deserticola extract and industrial preparation method and application thereof
KR100509843B1 (en) Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai
RU2322091C1 (en) Composition of biologically active substances and method for preparing its nanodispersion
KR100893779B1 (en) The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical
Riasat et al. Scrutinizing the therapeutic response of Phyllanthus exmblica's different doses to restore the immunomodulation potential in immunosuppressed female albino rats.
CN104739917B (en) The purposes of plant extract and preparation treatment hepatic fibrosis-renal tubular ectasia syndrome and the drug of liver cancer
KR100414187B1 (en) Hepatoprotective extract derived from Protaetia brevitarsis and its use
CN103181930B (en) Fructus Schisandrae Chinensis effective part of bee pollen form and the application in prevention hepar damnification thereof
Campuzano-Bublitz et al. Acute and chronic anti-hyperglycemic effect of Prosopis ruscifolia extract in normoglycemic and alloxan-induced hyperglycemic rats
KR101144715B1 (en) The oral medication for increasing of sperm numbers
Sènou et al. Efficacy of ethyl acetate fraction of Cocos nucifera aqueous extract on the treatment of anemia
Ziaul Amin et al. Evaluation of medicinal effects of Gynuraprocumbens leave extracts on oxidative, glycemic, lipidomics, and enzymatic profiles in alloxan-induced diabetic mice
RU2665968C1 (en) Method for obtaining an agent of choleretic, anti-inflammatory and antioxidant activity
TWI618540B (en) Composition for preventing renal toxicity caused by drug toxicity, preparation method thereof and Its use
Fernand et al. Evaluation of antihyperglycemic, antiradical and acute oral toxicity activities of aqueous leaves extract of Moringa oleifera Lam (Moringaceae) from Benin in normal rats
RU2404789C2 (en) Method for production of biologically active extract from pallas milkwort root
Amah et al. Hematological evaluation of aqueous and methanolic leaf extracts of Thaumatococcus daniellii and Alchornea cordifolia in Wistar rats
Aldhafiri et al. Hepatoprotective studies of methanolic leaf extract of Barringtonia acutangula (L) against carbon tetrachloride induced liver injury in wistar rats
Rahman et al. Anti-Inflammatory and Analgesic Activities of Ethanolic Extract of Glochidion Thomsonii (BARK)
Kumar Membrane Stabilizing and antioxidant activities of extracts from leaves of Elaeocarpus sphaericus
Sarkar et al. Study of hypoglycemic activity of aqueous extract of Leucas indica Linn. aerial parts on streptozotocin induced diabetic rats
Alfarajat et al. Reno-protective effect of Citrus sinensis by regulating antioxidant capability and gene expression in adenine-induced chronic kidney in rats

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130319

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20140108

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160203

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170411

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20180405

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20190409

Year of fee payment: 11